SYVA-BAX
SYVA-BAX
Authorised
- Clostridium perfringens, type A, alpha toxoid
- Clostridium perfringens, type B and C, beta toxoid
- Clostridium perfringens, type B and D, epsilon toxoid
- Clostridium septicum, toxoid
- Clostridium novyi, type B, alpha toxoid
- Clostridium tetani, toxoid
- Clostridium sordellii, toxoid
- Clostridium chauvoei, Inactivated
Product identification
Medicine name:
SYVA-BAX
Active substance:
- Clostridium perfringens, type A, alpha toxoid
- Clostridium perfringens, type B and C, beta toxoid
- Clostridium perfringens, type B and D, epsilon toxoid
- Clostridium septicum, toxoid
- Clostridium novyi, type B, alpha toxoid
- Clostridium tetani, toxoid
- Clostridium sordellii, toxoid
- Clostridium chauvoei, Inactivated
Target species:
-
Cattle
-
Sheep
-
Goat
-
Pig
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Clostridium perfringens, type A, alpha toxoid0.30international unit(s)1.00millilitre(s)
-
Clostridium perfringens, type B and C, beta toxoid10.00international unit(s)1.00millilitre(s)
-
Clostridium perfringens, type B and D, epsilon toxoid5.00international unit(s)1.00millilitre(s)
-
Clostridium septicum, toxoid2.50international unit(s)1.00millilitre(s)
-
Clostridium novyi, type B, alpha toxoid3.50international unit(s)1.00millilitre(s)
-
Clostridium tetani, toxoid2.50international unit(s)1.00millilitre(s)
-
Clostridium sordellii, toxoid100.00percentage protection1.00millilitre(s)
-
Clostridium chauvoei, Inactivated100.00percentage protection1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cattle
-
Meat and offal0day
-
- Sheep
-
Meat and offal0day
-
- Goat
-
Meat and offal0day
-
-
Intramuscular use
- Pig
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI03AB
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Available in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Syva S.A.U.
Responsible authority:
- Spanish Agency For Medicines And Health Products
Authorisation number:
- 2824 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 9/11/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 9/11/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?: